Structure and pharmacological actions of phyllocaerulein, a caerulein-like nonapeptide: its occurrence in extracts of the skin of Phyllomedusa sauvagei and related Phyllomedusa species.
1. The South American amphibian Phyllomedusa sauvagei contains in its skin large amounts of a polypeptide closely resembling caerulein in its pharmacological actions. This polypeptide, called phyllocaerulein, was obtained in a pure form, and upon acid hydrolysis, enzymic digestion and end-group determination experiments it proved to be a nonapeptide of the following composition Pyr-Glu-Tyr(SO(3)H)-Thr-Gly-Trp-Met-Asp-Phe-NH(2)It may be seen that caerulein and phyllocaerulein have in common the C-terminal heptapeptide and the N-terminal pyroglutamyl residue.2. Phyllocaerulein is indistinguishable from caerulein even in parallel bioassay. However, the former polypeptide seems to be somewhat more potent than the latter on all the preparations tested.3. In different batches of Phyllomedusa sauvagei skin the phyllocaerulein content ranged between 150 and 600 mug/g of fresh tissue.Phyllocaerulein or similar polypeptides occur also in the skin of several other Phyllomedusa species, among which are Phyll. burmeisteri, Phyll. dachnicolor, Phyll, helenae, Phyll. annae, Phyll. callidryas and Phyll. bicolor.4. The qualitative identification and quantitative estimation of caerulein-like polypeptides in crude skin extracts may be complicated by the concomitant occurrence of other active polypeptides. These, however, are poorly effective on some test preparations which seem to respond selectively to caerulein.5. Like that of caerulein, the biological significance of phyllocaerulein is completely obscure.
D000595:Amino Acid Sequence; D000663:Amphibians; D000818:Animals; D001681:Biological Assay; D001794:Blood Pressure / Q000187:drug effects; D002854:Chromatography, Paper; D005704:Gallbladder / Q000187:drug effects; D005750:Gastric Juice / Q000378:metabolism; D007082:Ileum / Q000187:drug effects; D010189:Pancreatic Juice / Q000378:metabolism; D010455:Peptides / Q000032:analysis* / Q000494:pharmacology*; D012867:Skin / Q000032:analysis
D010455:Peptides
Br J Pharmacol. 1969 Sep;37(1):185-97
5824930
Experientia. 1962 Aug 15;18:363-4
14466133
Experientia. 1968 Aug 15;24(8):771-3
5693208
Br J Pharmacol. 1968 Oct;34(2):311-29
4879882
Br J Pharmacol Chemother. 1966 Sep;27(3):479-85
5970899
Br J Pharmacol Chemother. 1968 May;33(1):48-58
5660165
Br J Pharmacol Chemother. 1968 May;33(1):59-71
5660166
Experientia. 1969 Jan 15;25(1):8-9
5766599
Br J Pharmacol. 1968 Oct;34(2):291-310
5687588
Arch Biochem Biophys. 1968 Apr;125(1):57-68
5649531
Br J Pharmacol Chemother. 1965 Oct;25(2):363-79
5866718